कंपनी का अवलोकन
ZeroStack Corp., also known as Flora Growth Corp., functions as an asset management entity that leverages artificial intelligence to deliver decentralized AI solutions while simultaneously engaging in the distribution of pharmaceutical goods and medical cannabis products for various health indications, including cancer therapies. The company operates within the broader Financial Services sector, specifically specializing in the Asset Management industry, which implies a focus on managing capital and providing investment-related services alongside its specialized product distribution activities. With a market capitalization of $21.59M and an annual revenue of $57.61M over the trailing twelve months, the organization maintains a workforce of 64 employees. These valuation and revenue metrics indicate that the company holds a relatively small market position compared to large-scale institutional asset managers, suggesting it operates with a niche focus rather than broad market dominance, yet it demonstrates significant revenue generation relative to its modest asset base and headcount.
वित्तीय स्वास्थ्य
The company reported total revenue of $57.61M for the trailing twelve months, yet it recorded a net income loss of $-15,921,000 and an EBITDA of $-13,713,000, revealing a substantial gap between top-line revenue and bottom-line profitability that points to a high-cost structure or significant operational expenditures that are not yet covered by gross margins. This negative earnings trajectory is further supported by a free cash flow of $-4,575,625, which indicates that the company is currently burning cash rather than generating liquidity, thereby limiting its immediate financial flexibility for capital expenditures or unplanned operational needs. Margin analysis shows a gross margin of 21.0%, suggesting that the cost of goods sold is substantial, while the operating margin stands at -33.5% and the profit margin at -27.7%, highlighting that overhead costs and other expenses are aggressively eroding profitability before reaching the bottom line. On the balance sheet, the company holds $13.10M in cash against $3.25M in debt, resulting in a debt-to-equity ratio of 5.00, which suggests a highly leveraged financial position where equity is relatively small compared to the debt obligations. Despite this leverage, the current ratio of 2.08 indicates that the company possesses more than double the current assets needed to cover its short-term liabilities, providing a buffer against immediate liquidity crises. Furthermore, the Return on Equity is -45.3% and the Return on Assets is -17.5%, metrics that reveal management has been unable to generate returns on the capital invested, reflecting a period of significant underperformance or heavy investment phases that have not yet translated into shareholder value.
मूल्यांकन आकलन
The valuation metrics present a complex picture, as the trailing P/E ratio is listed as N/A due to negative earnings, while the forward P/E is -8.52, implying that the market is pricing in future earnings recovery or expecting a turnaround rather than current profitability. The price-to-book ratio is 0.10, indicating that the market values the company at just 10% of its book value, which suggests a significant discount or that the market does not currently assign a premium to the company's assets. Additionally, the price-to-sales ratio is 0.37 and the EV/EBITDA is 0.08, alternative metrics that suggest the stock is trading at a fraction of its sales and earnings potential, often seen in distressed turnaround situations or highly speculative growth phases. The stock's price range over the past year has fluctuated between a 52-week low of $5.86 and a high of $47.00, meaning the current trading price sits significantly below the recent highs, reflecting the negative earnings and cash flow pressures. The beta value of 1.90 indicates that the stock is nearly twice as volatile as the broader market, meaning price swings will be much more extreme than the general market index, presenting higher risk for risk-averse investors.
Growth & Income
Revenue growth year-over-year has surged by 34.7%, demonstrating a strong expansion in top-line sales, whereas earnings growth is listed as N/A because the company is currently unprofitable, implying that revenue expansion has not yet translated into bottom-line gains. Since the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it follows a strategy of reinvesting all available earnings—or in this case, utilizing cash reserves—to fund its growth initiatives and operational scaling rather than distributing income to shareholders. The combination of high revenue growth but persistent negative net income and cash flow suggests the company is in a heavy investment or expansion phase where profitability is yet to be realized. Overall, the growth and income profile is characterized by rapid revenue expansion offset by significant operational losses and a complete absence of dividend income, relying entirely on capital appreciation potential and future profitability to attract investors.